2007
DOI: 10.1016/j.jsbmb.2007.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Activation of estrogen receptor-β by a special extract of Rheum rhaponticum (ERr 731®), its aglycones and structurally related compounds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
29
1
1

Year Published

2007
2007
2021
2021

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 41 publications
(32 citation statements)
references
References 53 publications
1
29
1
1
Order By: Relevance
“…It has also been reported that activation of estrogen receptors is associated with the up-regulation of eNOS expression by resveratrol. Both piceatannol and resveratrol act as estrogen receptor agonists [39,40], and estrogen receptor activation is associated with the up-regulation of eNOS protein levels [41]. Even in the present study, piceatannol activation of estrogen receptors may be associated with the up-regulation of eNOS expression.…”
Section: Discussioncontrasting
confidence: 57%
“…It has also been reported that activation of estrogen receptors is associated with the up-regulation of eNOS expression by resveratrol. Both piceatannol and resveratrol act as estrogen receptor agonists [39,40], and estrogen receptor activation is associated with the up-regulation of eNOS protein levels [41]. Even in the present study, piceatannol activation of estrogen receptors may be associated with the up-regulation of eNOS expression.…”
Section: Discussioncontrasting
confidence: 57%
“…According to recent investigations, the main active components in this extract are hydroxystilbenes Wober et al, 2007).…”
Section: Introductionmentioning
confidence: 97%
“…We observed high levels of transgenic ER␤ mRNA and protein levels in RNDA cells using quantitative real-time PCR and PAGE electrophoresis followed by Western blotting. Moreover, the proof of functionality and specificity of estrogen receptor action was carried out using a reporter gene assay utilizing a plasmid containing an ERE-luciferase construct, as has been described for other cell lines by our group and collaborators [37,38]. Subsequently, we tested the estrogen-like bioactivity of GEN, DAI and EQ in addition to NAR, 8-PN, 6-DMAN and 7-O-PN utilizing the same reporter gene assay.…”
Section: Introductionmentioning
confidence: 99%